Exciting Partnership to Enhance Prostate Cancer Screening
Nakostics Inc. and Protean BioDiagnostics Inc. have announced an important partnership that promises to improve men's health by delivering CDX Prostate in the United States. This collaboration focuses on refining the identification process for aggressive prostate cancer using cutting-edge technologies.
Transforming Prostate Cancer Diagnostics
The CDX Prostate test utilizes a blend of biological data and medical insights, powered by AI-based learning models, to generate a risk score that indicates the likelihood of aggressive prostate cancer. This innovative tool provides vital support to both doctors and patients, aiding them in making well-informed decisions about whether to proceed with biopsies after troubling PSA test results or unusual physical examinations.
The Significance of Early Detection
Dr. John Lewis, CEO of Nanostics and an oncology expert, emphasized the importance of this collaboration. He said, "By offering CDX Prostate to men in the U.S., we can facilitate earlier detection of aggressive prostate cancer, which is key to improving patient outcomes and reducing the risks linked to unnecessary overdiagnosis." This forward-thinking strategy represents a significant advancement in the early detection of prostate cancer.
Protean's Dedication to Precision Medicine
Dr. Anthony Magliocco, CEO of Protean BioDiagnostics, shared his excitement about including CDX Prostate in their cancer screening programs. His remarks highlight Protean's commitment to providing top-notch precision medicine solutions and the positive impact this partnership will have on patient care.
Understanding How CDX Prostate Works
The CDX Prostate test presents a novel method for prostate cancer screening. By employing an advanced algorithm that evaluates a range of biological data, the test determines a unique risk score. This score is essential for assessing the likelihood of a patient having aggressive prostate cancer.
A Thorough Evaluation
For men with raised PSA levels, this test proves especially useful, assisting healthcare providers in deciding whether more invasive approaches, like biopsies, are necessary. With CDX Prostate, men can gain a clearer understanding of their health, promoting a more customized approach to their medical care.
Testing Services Offered
Protean BioDiagnostics provides its testing services at a CLIA-certified laboratory located in Orlando, Florida, ensuring that every test meets the highest quality standards. For those wishing to learn more about ordering the CDX Prostate test, they are encouraged to check out Protean's resources directly.
CDX Prostate in Canada
In Canada, CDX Prostate testing is available in multiple provinces through Nanostics' CPSA-accredited laboratory in Edmonton, Alberta. This means patients in Canada can also take advantage of this groundbreaking testing solution. Furthermore, specialized testing services are offered in Quebec by CDL Laboratories.
About the Companies Involved
Protean BioDiagnostics is dedicated to transforming precision care diagnostics, ensuring that advanced technologies are accessible to patients worldwide. Their Protean MAPS™ System, along with Virtual Tumor Boards, highlights their commitment to innovation in diagnostic solutions.
Nanostics: Leading the Way in Advanced Diagnostics
As a private firm based in Canada, Nanostics focuses on creating noninvasive diagnostic technologies. Their flagship product, CDX Prostate, also referred to as ClarityDX Prostate in Canada, showcases their ability to improve the accuracy of prostate cancer detection through sophisticated machine learning algorithms.
Frequently Asked Questions
What does the CDX Prostate test aim to achieve?
The CDX Prostate test assesses the risk of aggressive prostate cancer, helping men and their healthcare providers make informed decisions about additional testing.
How is the CDX Prostate test conducted?
This test integrates biological data and artificial intelligence to calculate a risk score for prostate cancer, enhancing the precision of cancer screening.
Where can I access the CDX Prostate test?
The test is available in the United States through Protean BioDiagnostics and in Canada through Nanostics, with additional services specifically in Quebec.
Why is early detection of prostate cancer important?
Detecting prostate cancer early allows for timely interventions, which can lead to better health outcomes and lower the likelihood of advanced disease progression.
How do I order the CDX Prostate test?
Those interested in the test can visit the websites of Protean BioDiagnostics or Nanostics to find detailed information on the ordering process.
